بدائل البحث:
nsn decrease » mean decrease (توسيع البحث), use decreased (توسيع البحث), ash decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
ng decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), we decrease (توسيع البحث)
50 nsn » 50 ns (توسيع البحث)
50 nn » 50 ns (توسيع البحث), 50 n (توسيع البحث), 59 nn (توسيع البحث)
50 ng » 50 mg (توسيع البحث), 10 ng (توسيع البحث), 5 ng (توسيع البحث)
nsn decrease » mean decrease (توسيع البحث), use decreased (توسيع البحث), ash decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
ng decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), we decrease (توسيع البحث)
50 nsn » 50 ns (توسيع البحث)
50 nn » 50 ns (توسيع البحث), 50 n (توسيع البحث), 59 nn (توسيع البحث)
50 ng » 50 mg (توسيع البحث), 10 ng (توسيع البحث), 5 ng (توسيع البحث)
-
81
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation
منشور في 2022"…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"
-
82
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation
منشور في 2022"…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"
-
83
-
84
Data_Sheet_1_Marathon Running Increases Synthesis and Decreases Catabolism of Joint Cartilage Type II Collagen Accompanied by High-Energy Demands and an Inflamatory Reaction.PDF
منشور في 2021"…Mean sC2C levels (220.83 ± 39.50 ng/ml) decreased post-race (188.67 ± 38.52 ng/ml) (p = 0.002). …"
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
Maternal Transfer of 2‑Ethylhexyl Diphenyl Phosphate Leads to Developmental Toxicity Possibly by Blocking the Retinoic Acid Receptor and Retinoic X Receptor in Japanese Medaka (Ory...
منشور في 2021"…After adult female medaka were exposed to EHDPP at 156, 405, and 1161 ng/L for 35 days, the embryonic EHDPP concentrations (364–4824 ng/g lipid weight (lw)) were higher than those in the maternal tissues (15.0–4166 ng/g lw), showing notable maternal transfer. …"
-
94
Inhibition of pan- and HDAC isoform activities.
منشور في 2024"…Pharmacokinetic evaluation demonstrates an area under the curve (AUC) of 5227.55 ng/ml × h with an elimination half-life of 1.26 h following intravenous administration in a rat model. …"
-
95
-
96
Antibodies used for flow cytometry experiments.
منشور في 2023"…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …"
-
97
Subject flow diagram.
منشور في 2023"…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …"
-
98
-
99
-
100